Research and Markets: Tuberculosis - Pipeline Review, Q4 2010

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/1ead25/tuberculosis_pip) has announced the addition of Global Markets Direct's new report "Tuberculosis - Pipeline Review, Q4 2010" to their offering.

Tuberculosis Pipeline Review, Q4 2010, provides an overview of the Tuberculosis therapeutic pipeline. This report provides information on the therapeutic development for Tuberculosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tuberculosis. Tuberculosis-Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources Scope

A snapshot of the global therapeutic scenario for Tuberculosis.
A review of the Tuberculosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the Tuberculosis pipeline on the basis of therapeutic class, route of administration and molecule type.
Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
Key discontinued pipeline projects.
Latest news and deals relating to the products.

Key Topics Covered:

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tuberculosis Overview
Therapeutics Development
An Overview of Pipeline Products for Tuberculosis
Tuberculosis Therapeutics under Development by Companies
Tuberculosis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in Tuberculosis Therapeutics Development
and much more...

For more information visit http://www.researchandmarkets.com/research/1ead25/tuberculosis_pip

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Recent Stories from Research and Markets

Research and Markets: Canada Metals Report Q2 2012 - Canadian Zinc Production Will Shrink 2% in 2012 Following the Closure of Xstrata's Zinc and Copper Plants

May 25, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vstjjj/canada_metals_repo) has announced the addition of the "Canada Metals Report Q2 2012" report to their... more »
Research and Markets: Four-S Fortnightly Indian Mediatainment Track Vol. 39 - Issue 4 - TV Has Generated 6 M&A Deals with Disclosed Deal Value of $878mn

May 25, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qkbs5d/fours_fortnightly) has announced the addition of the "Four-S Fortnightly Indian Mediatainment Track ... more »
Research and Markets: Footwear in Italy - Sector Financials: 2011-201

May 25, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bpj44s/footwear_in_italy) has announced the addition of the "Footwear in Italy - Sector financials" report ... more »